Document Detail

Systematic reviews and meta-analyses in the new age of transparency.
MedLine Citation:
PMID:  20648031     Owner:  NLM     Status:  MEDLINE    
Systematic reviews and meta-analyses are useful in integrating large amounts of data to inform medical practice, and it is likely that the already large number of published meta-analyses will increase further as the provisions in the Food and Drug Administration Amendments Act and other forces result in dramatically increased transparency about the design and results of clinical trials. It is critical for readers of these analyses to be capable of assessing the quality of this research.
P K Honig
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  88     ISSN:  1532-6535     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-21     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  155-8     Citation Subset:  AIM; IM    
Collegeville, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic
Data Interpretation, Statistical
Meta-Analysis as Topic*
Reference Standards
Review Literature as Topic*
United States
United States Food and Drug Administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  ASCPT News.
Next Document:  ASCPT Task Force for advancing pharmacometrics and integration into drug development.